These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11889596)
1. Microcalcifications of breast cancer and atypical cystic lobules associated with infiltration of foam cells expressing osteopontin. Oyama T; Sano T; Hikino T; Xue Q; Iijima K; Nakajima T; Koerner F Virchows Arch; 2002 Mar; 440(3):267-73. PubMed ID: 11889596 [TBL] [Abstract][Full Text] [Related]
2. Atypical cystic lobule of the breast: an early stage of low-grade ductal carcinoma in-situ. Oyama T; Iijima K; Takei H; Horiguchi J; Iino Y; Nakajima T; Koerner F Breast Cancer; 2000; 7(4):326-31. PubMed ID: 11114859 [TBL] [Abstract][Full Text] [Related]
3. Expression of parathyroidlike protein in normal, proliferative, and neoplastic human breast tissues. Liapis H; Crouch EC; Grosso LE; Kitazawa S; Wick MR Am J Pathol; 1993 Oct; 143(4):1169-78. PubMed ID: 8214010 [TBL] [Abstract][Full Text] [Related]
4. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. de Candia P; Akram M; Benezra R; Brogi E Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866 [TBL] [Abstract][Full Text] [Related]
5. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. Ikeda T; Shirasawa T; Esaki Y; Yoshiki S; Hirokawa K J Clin Invest; 1993 Dec; 92(6):2814-20. PubMed ID: 8254036 [TBL] [Abstract][Full Text] [Related]
6. Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci. Hirota S; Ito A; Nagoshi J; Takeda M; Kurata A; Takatsuka Y; Kohri K; Nomura S; Kitamura Y Lab Invest; 1995 Jan; 72(1):64-9. PubMed ID: 7837792 [TBL] [Abstract][Full Text] [Related]
7. [Role of osteopontin in the formation of microcalcifications in breast cancer]. Tókés AM; Krausz J; Kulka J; Jäckel M; Kádár A Orv Hetil; 2002 Aug; 143(31):1841-6. PubMed ID: 12187578 [TBL] [Abstract][Full Text] [Related]
8. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
9. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast. Latta EK; Tjan S; Parkes RK; O'Malley FP Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013 [TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53]. Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603 [TBL] [Abstract][Full Text] [Related]
11. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
12. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings]. Piubello Q; Montemezzi S; D'Atri C Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993 [TBL] [Abstract][Full Text] [Related]
13. Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754 [TBL] [Abstract][Full Text] [Related]
14. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma. Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897 [TBL] [Abstract][Full Text] [Related]
15. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155 [TBL] [Abstract][Full Text] [Related]
16. Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases. Skalova A; Ryska A; Kajo K; Di Palma S; Kinkor Z; Michal M Histopathology; 2005 Jan; 46(1):43-9. PubMed ID: 15656885 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of clusterin in human breast carcinoma. Redondo M; Villar E; Torres-Muñoz J; Tellez T; Morell M; Petito CK Am J Pathol; 2000 Aug; 157(2):393-9. PubMed ID: 10934144 [TBL] [Abstract][Full Text] [Related]
18. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238 [TBL] [Abstract][Full Text] [Related]
19. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207 [TBL] [Abstract][Full Text] [Related]
20. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis? Kwaepila N; Burns G; Leong AS Pathology; 2006 Apr; 38(2):125-31. PubMed ID: 16581652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]